Communicating risk with aneuploidy screening: things are never as simple as they appear to be.
BJOG. 2017 Sep 05;:
Authors: Robinson J, Wilkins-Haug L
Abstract
The introduction of a new technology, such as an aneuploidy screening test, is an opportunity for advancement, but it is also a risk for misuse and harm. The enthusiasm of researchers, prospective parents, and the biomedical industry should be balanced with a measured approach. Optimal counseling for a particular screening or prenatal diagnostic test to be chosen, or declined, involves a comprehensive understanding of the available tests, the conditions to be screened for, time, and good communication skills. This article is protected by copyright. All rights reserved.
PMID: 28872762 [PubMed - as supplied by publisher]
from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2j2Nu5I
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,